Life sciences firms are embedding AI across adverse event (AE) case processing to create scale, transform compliance, and enhance patient safety.
Cora PharmacoVigilance Highlights
50%reduction in case-processing costs
100%accuracy when extracting key data across all AE source types
Quality data and insights
Cora PharmacoVigilance embeds AI and machine learning to improve data quality and insight across regulatory operations.
Enhanced user experience
Our guided user interface helps manually verify records and streamline quality control.
Touchless AE processing automatically generates notifications and follow-up alerts without human intervention.
We protect patients with artificial intelligence that identifies patterns in data to foresee potential adverse events. We're revolutionizing pharmacovigilance end to end with technology that learns and keeps patients safe.Learn More
Adverse event case processing
Cora PharmacoVigilance's case processing capabilities support you from acquisition to medical review, distribution, and submission. You can say goodbye to legacy case processing systems—and cut IT costs, too.Learn More
Configurable workflow engine
Our technology automatically generates notifications and follow-up alerts. What's more, it processes most AE cases without human intervention. And when people are called for, the product intelligently directs users through data fields, which streamlines quality control.
Integration with all leading systems
Cora PharmacoVigilance integrates with all leading safety systems so you won't lose any important information as transition gets underway. You get value up front without the cut-over challenges of a complete system replacement.